Eclepens, Switzerland

Btg Eclepens S.a.

USPTO Granted Patents = 12

% Expired Patents = 25.0



Forward Citations = 37

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Silvano Freti (7 out of 9 patents)

silverMedal Alexandre Claudon (3 out of 3 patents)

bronzeMedal Jean Francois Laithier (2 out of 2 patents)

4.  Günter Bellmann (2 out of 2 patents)

5.  Bernard Hansz (2 out of 4 patents)

6.  Tore Eriksson (1 out of 8 patents)

7.  Christian Coddet (1 out of 9 patents)

8.  Lothar Burchardt (1 out of 1 patent)

9.  Christian Codet (1 out of 1 patent)

10.  Philippe Crevoisier (1 out of 1 patent)

11.  Jaime Perez (1 out of 1 patent)

12.  Antoine Beran (1 patent)

13.  Jean-Francois Laithier (0 patent)

14.  Guenter Bellmann (0 patent)

15.  Jean-Francois Laithier (0 patent)


12 patents:

Company Overview
Btg Eclepens S.a. is a Swiss company located in Eclepens, specializing in the development and manufacturing of advanced medical technologies. The organization focuses on innovative solutions that enhance patient care and improve clinical outcomes. With a commitment to research and development, Btg Eclepens engages in various domains within the healthcare sector, aiming to address complex medical challenges through cutting-edge technology and expertise. Its geographic presence in Switzerland positions it within a robust ecosystem of healthcare innovation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

12 Patents

#1 in Eclepens

#928 in Switzerland

#48,209 in the World

Eclepens, CH
Eclepens, Switzerland
Forward Citations = 37

11 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Btg Eclepens S.a.. Retrieved from https://idiyas.com/company/btg-eclepens-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…